Adjuvant chemotherapy improves overall survival in patients with stage IB non-small cell lung cancer
The use of adjuvant chemotherapy in early-stage non-small cell lung cancer (NSCLC) patients improves overall survival (OS) and 5-year OS in patients with tumor sizes ranging from 3 - 7 cm.
Jun 13, 2016
0
4